Bilingua‐DPP‐IV: A Bimodal Fusion Convolutional Neural Network Model for Prediction of Dipeptidyl Peptidase IV Inhibitory Peptides
ChemMedChem · 2026-10-28 · 21 (20)
DOI: 10.1002/cmdc.70551 ↗At a glance
Journal article in ChemMedChem, published online on 2026-10-23. Written by Zhixing Zhang and 9 co-authors. Institution: Shanghai Frontiers Science Center of Optogenetic Techniques for Cell Metabolism, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East…. Major MEDLINE topics: Dipeptidyl-Peptidase IV Inhibitors, Dipeptidyl Peptidase 4, Peptides, Neural Networks, Computer. 32 references. Funded by: National Natural Science Foundation of China, Shanghai Frontiers Science Center of Optogenetic Techniques for Cell Metabolism.
Abstract (original language)
Motivation: Dipeptidyl peptidase IV (DPP‐IV) is a key therapeutic target for type 2 diabetes, and its inhibitory peptides are a promising class of therapeutic agents. However, the discovery of these promising drugs has been restricted, as many existing computational predictors are based on datasets that have remained static for several years. Results: Here, we first presented a newly curated and expanded benchmark dataset, then introduced Bilingua‐DPP‐IV, a bimodal deep learning framework that integrates features from both amino acid sequences and molecular structures. Our approach leveraged embeddings from the large‐scale pretrained models ESM C and Uni‐Mol2, processed through a convolutional neural network with an optimized gated fusion mechanism. On an independent test set, the Bilingua‐DPP‐IV ensemble model achieved a Matthews correlation coefficient of 0.764 and an area under the receiver operating characteristic curve of 0.963. On an external validation set, the model also demonstrated an accuracy of 0.898, exceeding the performance of existing state‐of‐the‐art predictors, such as StructuralDPPIV.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Shanghai Frontiers Science Center of Optogenetic Techniques for Cell Metabolism, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai, China.
ORCID profiles: Weihua Li, Guixia Liu, Yun Tang
Funding
- National Natural Science Foundation of China
- Shanghai Frontiers Science Center of Optogenetic Techniques for Cell Metabolism
Cite
APA
Zhang, Z., Yu, Q., Yang, C., Duan, H., Fang, J., Xu, J., Gong, C., Li, W., Liu, G., & Tang, Y. (2026). Bilingua‐DPP‐IV: A Bimodal Fusion Convolutional Neural Network Model for Prediction of Dipeptidyl Peptidase IV Inhibitory Peptides. ChemMedChem, 21(20). https://doi.org/10.1002/cmdc.70551
Vancouver
Zhang Z, Yu Q, Yang C, Duan H, Fang J, Xu J, et al. Bilingua‐DPP‐IV: A Bimodal Fusion Convolutional Neural Network Model for Prediction of Dipeptidyl Peptidase IV Inhibitory Peptides. ChemMedChem. 2026;21(20). doi:10.1002/cmdc.70551
BibTeX
@article{Zhang2026,
author = {Zhang, Zhixing and Yu, Qiule and Yang, Chen and Duan, Hao and Fang, Jiaojiao and Xu, Jiahao and Gong, Changda and Li, Weihua and Liu, Guixia and Tang, Yun},
title = {Bilingua‐DPP‐IV: A Bimodal Fusion Convolutional Neural Network Model for Prediction of Dipeptidyl Peptidase IV Inhibitory Peptides},
journal = {ChemMedChem},
year = {2026},
volume = {21},
number = {20},
doi = {10.1002/cmdc.70551}
}
EUVIMED